Symposium 6: Lessons from The Life's end Benefits of cannaBidiol and tetrahydrocannabinol (LiBBY) Study: Efficacy, Implementation, and Future Therapeutic Development in Advanced Dementia

About this session

Presentations: (1) Domain-Specific Effects of THC/CBD on Agitation in Advanced Dementia: Cohen-Mansfield Agitation Inventory Analyses from the LiBBY Study; (2) Effects of THC/CBD on NPI-Q Agitated Symptoms in Advanced Dementia: Results from the Double-Blind, Placebo-Controlled LiBBY Study; (3) Advancing Trials in Dementia: Lessons from LiBBY and a Future Research Agenda for the Alzheimer's Clinical Trial Consortium (ACTC).

Speakers

• OB

  Olga Brawman-Mintzer

  Medical University of South Carolina and Ralph H. Johnson VA Health Care System

  Chair

• JM

  Jacobo Mintzer

  Medical University of South Carolina

  Speaker

• BR

  Brigid Reynolds

  Georgetown University

  Speaker

• PA

  Paul Aisen

  Alzheimer's Therapeutic Research Institute, University of Southern California

  Speaker